These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34668809)
1. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies. Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809 [TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies. Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187 [TBL] [Abstract][Full Text] [Related]
3. Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network. Kodde C; Bonsignore M; Schöndube D; Bauer T; Hohenstein S; Bollmann A; Meier-Hellmann A; Kuhlen R; Nachtigall I Infection; 2023 Feb; 51(1):119-127. PubMed ID: 35657531 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA; J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563 [TBL] [Abstract][Full Text] [Related]
5. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan". Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality. Aumann S; Tsubary U; Nachmias B; Ben Yehuda D; Lavie D; Goldschmidt N; Vainstein V; Libster D; Saban R; Shaulov A; Israel S; Avni B; Grisariu S; Bdolah-Amram T; Gatt M; Zimran E Eur J Haematol; 2023 Jul; 111(1):135-145. PubMed ID: 37096337 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study. Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 versus seasonal influenza: myocardial injury and prognostic importance. Mizera L; Zdanyte M; Gernert J; Petersen-Uribe Á; Müller K; Gawaz MP; Greulich S; Rath D BMC Infect Dis; 2022 Jun; 22(1):539. PubMed ID: 35692037 [TBL] [Abstract][Full Text] [Related]
9. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study. Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children. Song X; Delaney M; Shah RK; Campos JM; Wessel DL; DeBiasi RL JAMA Netw Open; 2020 Sep; 3(9):e2020495. PubMed ID: 32897374 [TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of SARS-CoV-2. Zhang J; Huang X; Tao Z Front Public Health; 2022; 10():981233. PubMed ID: 36062112 [TBL] [Abstract][Full Text] [Related]
13. [SARS-COV-2 infection in patients with hematological malignancies and transplants]. Herrera F; Bues F; Rojas R; Temporiti E; Videla C; Dupont J; Bonvehí P Medicina (B Aires); 2021; 81(3):396-400. PubMed ID: 34137699 [TBL] [Abstract][Full Text] [Related]
14. Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic. Seval GC; Topçuoğlu P; Demirer T Turk J Med Sci; 2021 Dec; 51(6):2799-2809. PubMed ID: 33705648 [TBL] [Abstract][Full Text] [Related]
15. Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies. Ferrari S; Caprioli C; Weber A; Rambaldi A; Lussana F Leuk Lymphoma; 2021 Jun; 62(6):1490-1496. PubMed ID: 33461387 [TBL] [Abstract][Full Text] [Related]